← Back to Strain Guide

Photo Book

Hyper-realistic image of Blue Blood cannabis buds, olive green with purple and blue undertones, coated in white trichomes on a sleek slate surface with neon blue lighting. Strain name "Blue Blood" and stats (Indica-Dominant Hybrid, THC: 15-20%, CBD: 10%) displayed in modern white typography.

Blue Blood

Bred by Medicann Seeds, Pacific Seed Bank

Cannabinoid Profile

THC15.00%
CBD10.00%
CBG0.50%

About Blue Blood

Meet Blue Blood, the indica-dominant hybrid that’s here to steal the show with its chill vibes and royal flair. Born from the legendary OG Kush and Blueberry, this strain (70% indica, 30% sativa) packs a potent punch with THC levels of 15-20% and a hefty 10% CBD to keep things smooth. Its dense, spade-shaped buds are a sight to behold—olive green with bold purple and blue hues, blanketed in frosty white trichomes and dripping with sweet, sticky resin. Inhale, and you’re hit with a mouthwatering mix of sweet blueberry spice, pine, and a diesel kick that lingers like a late-night city vibe. The high creeps in slow, wrapping you in a numbing body buzz that melts away stress, pain, and sleepless nights while sparking a gentle mental lift—think happy chats and euphoric giggles. Perfect for tackling chronic pain, inflammation, muscle spasms, insomnia, or even multiple sclerosis, Blue Blood’s high CBD content keeps the psychoactivity in check for a clear-headed, full-body calm. Whether you’re a newbie or a seasoned grower, this gem from Medicann Seeds (with an autoflowering twist from Pacific Seed Bank) thrives indoors or out, blooming in about 9 weeks. Side effects? Just the usual dry mouth and eyes—nothing a glass of water can’t fix. Light up Blue Blood and let its urban-cool energy take you to a place of pure relaxation.

Reported Effects

RelaxedSleepyHungryTalkativeFocused

Common Flavors

SweetBlueberryEarthy

Potential Medical Uses

Chronic paininflammationinsomniamuscle spasmsmultiple sclerosis

Dominant Terpenes

Myrcene

10

Pinene

20

Limonene

40

Caryophyllene

5

Session Reports